Clari Vest Asset Management LLC Allakos Inc. Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $35,858 - $469,266	-4,194 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$76.53 - $110.43 $9,107 - $13,141	-119 Reduced 2.76%	4,194 $444,000
Q2 2021 Aug 09, 2021	BUY	$85.37 - $114.1 $939 - $1,255	11 Added 0.26%	4,313 $368,000
Q1 2021 May 13, 2021	SELL	$109.73 - $153.66 $32,919 - $46,098	-300 Reduced 6.52%	4,302 $494,000
Q4 2020 Feb 09, 2021	SELL	$79.58 - $152.45 $486,870 - $932,689	-6,118 Reduced 57.07%	4,602 $644,000
Q3 2020 Nov 09, 2020	SELL	$66.43 - $90.99 $35,008 - $47,951	-527 Reduced 4.69%	10,720 $873,000
Q2 2020 Aug 12, 2020	BUY	$44.04 - $80.69 $495,317 - $907,520	11,247 New	11,247 $808,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.